Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1977 Aug 20;117(4):341–345.

Leukocyte transfusions for the prophylaxis and treatment of infections associated with granulocytopenia.

J E Curtis, R Hasselback, D E Bergsagel
PMCID: PMC1879729  PMID: 407998

Abstract

The role of leukocyte transfusions in the prevention and treatment of infections in adults with granulocytopenia was investigated. Leukocytes were obtained from healthy volunteers by continuous-flow centrifugation. Histocompatibility antigen (HLA)-matched leukocytes were used to assess the prophylactic value of leukocyte transfusions. Seven patients with acute myelogenous leukemia received HLA-matched leukocytes during the period of maximal granulocytopenia associated with initial remission induction therapy; 20 concurrently treated patients who did not receive leukocyte transfusions were the control group. The patients receiving HLA-matched leukocytes had significantly fewer (P = 0.043) infectious episodes (not bacteriologically proven) during the study period, and remission occurred in 5 of the 7, compared with 10 of the 20 controls. In addition, 52 series of two or more ABO-compatible transfusions were given to 50 patients with proven infection or elevated temperature presumed due to infection and a granulocyte count of less than 0.5 X 10(9)/L. Response, indicated by a decrease in temperature, occurred in 23 patients. Leukocyte transfusions thus have an important adjuvant role in the management of patients with severe granulocytopenia.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abu-Zahra H., Clarysse A., Cowan D. H., Hasselback R., Bergsagel D. E. Treatment of acute myeloblastic leukemia in adults: remission induction with a combination of cyclophosphamide, cytarabine and vincristine. Can Med Assoc J. 1972 Dec 9;107(11):1073–1078. [PMC free article] [PubMed] [Google Scholar]
  2. Bodey G. P., Buckley M., Sathe Y. S., Freireich E. J. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966 Feb;64(2):328–340. doi: 10.7326/0003-4819-64-2-328. [DOI] [PubMed] [Google Scholar]
  3. Bodey G. P., Middleman E., Umsawadi T., Rodriguez V. Infections in cancer patients. Results with gentamicin sulfate therapy. Cancer. 1972 Jun;29(6):1697–1701. doi: 10.1002/1097-0142(197206)29:6<1697::aid-cncr2820290638>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  4. Boggs D. R. Transfusion of neutrophils as prevention or treatment of infection in patients with neutropenia. N Engl J Med. 1974 May 9;290(19):1055–1062. doi: 10.1056/NEJM197405092901906. [DOI] [PubMed] [Google Scholar]
  5. Chang H. Y., Rodriguez V., Narboni G., Bodey G. P., Luna M. A., Freireich E. J. Causes of death in adults with acute leukemia. Medicine (Baltimore) 1976 May;55(3):259–268. doi: 10.1097/00005792-197605000-00005. [DOI] [PubMed] [Google Scholar]
  6. Fortuny I. E., Bloomfield C. D., Hadlock D. C., Goldman A., Kennedy B. J., McCullough J. J. Granylocyte transfusion: a controlled study in patients with acuute nonlymphocytic leukemia. Transfusion. 1975 Nov-Dec;15(6):548–558. doi: 10.1046/j.1537-2995.1975.15676082229.x. [DOI] [PubMed] [Google Scholar]
  7. Freireich E. J., Judson G., Levin R. H. Separation and collection of leukocytes. Cancer Res. 1965 Oct;25(9):1516–1520. [PubMed] [Google Scholar]
  8. Gehan E. A., Freireich E. J. Non-randomized controls in cancer clinical trials. N Engl J Med. 1974 Jan 24;290(4):198–203. doi: 10.1056/NEJM197401242900405. [DOI] [PubMed] [Google Scholar]
  9. Graw R. G., Jr, Herzig G., Perry S., Henderson E. S. Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. N Engl J Med. 1972 Aug 24;287(8):367–371. doi: 10.1056/NEJM197208242870801. [DOI] [PubMed] [Google Scholar]
  10. Higby D. J., Henderson E. S. Granulocyte transfusion therapy. Annu Rev Med. 1975;26:289–316. doi: 10.1146/annurev.me.26.020175.001445. [DOI] [PubMed] [Google Scholar]
  11. Higby D. J., Yates J. W., Henderson E. S., Holland J. F. Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. N Engl J Med. 1975 Apr 10;292(15):761–766. doi: 10.1056/NEJM197504102921501. [DOI] [PubMed] [Google Scholar]
  12. Lowenthal R. M., Grossman L., Goldman J. M., Storring R. A., Buskard N. A., Park D. S., Murphy B. C., Spiers A. S., Galton D. A. Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia. Lancet. 1975 Feb 15;1(7903):353–358. doi: 10.1016/s0140-6736(75)91276-3. [DOI] [PubMed] [Google Scholar]
  13. McCredie K. B., Freireich E. J., Hester J. P., Vallejos C. Leukocyte transfusion therapy for patients with host-defense failure. Transplant Proc. 1973 Sep;5(3):1285–1289. [PubMed] [Google Scholar]
  14. McCulloch E. A., Mak T. W., Price G. B., Till J. E. Organization and communication in populations of normal and leukemic hemopoietic cells. Biochim Biophys Acta. 1974 Dec 31;355(3-4):260–299. doi: 10.1016/0304-419x(74)90013-4. [DOI] [PubMed] [Google Scholar]
  15. Messner H. A., McCulloch E. A. Interacting cell populations affecting granulopoietic colony formation by normal and leukemic human marrow cells. Blood. 1973 Nov;42(5):701–710. [PubMed] [Google Scholar]
  16. Rubin S. H., Cowan D. H. Assay of granulocytic progenitor cells in human peripheral blood. Exp Hematol. 1973;1(2):127–131. [PubMed] [Google Scholar]
  17. Schiffer C. A., Buchholz D. H., Aisner J., Betts S. W., Wiernik P. H. Clinical experience with transfusion of granulocytes obtained by continuous flow filtration leukopheresis. Am J Med. 1975 Mar;58(3):373–381. doi: 10.1016/0002-9343(75)90603-8. [DOI] [PubMed] [Google Scholar]
  18. Shohet S. B. Morphologic evidence for the in vivo activity of transfused chronic myelogenous leukemia cells in a case of massive staphylococcal septicemia. Blood. 1968 Jul;32(1):111–118. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES